De Caro, C;
Iannone, LF;
Citraro, R;
Striano, P;
De Sarro, G;
Constanti, A;
Cryan, JF;
(2019)
Can we ‘seize’ the gut microbiota to treat epilepsy?
Neuroscience & Biobehavioral Reviews
, 107
pp. 750-764.
10.1016/j.neubiorev.2019.10.002.
Preview |
Text
Constanti Review Gut-Microbiota epilepsy_Final.pdf - Accepted Version Download (1MB) | Preview |
Abstract
The gut-microbiota, the complex intestinal microbial ecosystem essential to health, is an emerging concept in medicine. Several studies demonstrate a microbiota-gut-brain bidirectional connection via neural, endocrine, metabolic and immune pathways. Accordingly, the gut microbiota has a crucial role in modulating intestinal permeability, to alter local/peripheral immune responses and in production of essential metabolites and neurotransmitters. Its alterations may consequently influence all these pathways that contribute to neuronal hyper-excitability and mirrored neuroinflammation in epilepsy and similarly other neurological conditions. Indeed, pre- and clinical studies support the role of the microbiome in pathogenesis, seizure modulation and responses to treatment in epilepsy. Up to now, researchers have focussed attention above all on the brain to develop antiepileptic treatments, but considering the microbiome, could extend our possibilities for developing novel therapies in the future. We provide here a comprehensive overview of the available data on the potential role of gut microbiota in the physiopathology and therapy of epilepsy and the supposed underlying mechanisms.
Archive Staff Only
 |
View Item |
